1Hiroshi K, Hiroshi N, Misao S, et al. Effects of a novel free radicalscavenger, MCI-186, on ischemic brain damage in the rat distal middlecerebral artery occlusion model[J]. J Pha~l Exp Ther, 1997,281(2) :921.
2Berderson JB, Pitts LH, Tsuji M, et al. Rat middle cerebral artery oc-clusion: evaluation of the model and development of a neurologic ex-amination[J]. Stroke, 1986,17(3) :472.
3Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebralartery occlusion without craniectomy in rats[ J ]. Stroke, 1989,20( 1 ):84.
4Hallenbeck JM, Dutka AJ. Background review and current concepts ofreperfusion injmy[J]. Arch Neurol, 1990, 47(5): 1245.
5Wen Y, Yang S, Liu R, et al. Estrogen attenuates nuclear factor-kap-pa B activation induced by transient cerebral ischemia[ J]. Brain Res,2004,1008(2): 147.
6Nomoto Y, Yamamoto M, Fukushima T, et al. Expression of nuclearfactor-kappa B and tumor necrosis factor-alfa in the mouse brain afterexperimental thermal ablation injury [ J ]. Neurosurg, 2001,48 ( 1 ):158.
7横田慎一 熊毅雄治 内海光朝.A Pharmacokinetic Study of MCI—186,a novel drug for cerebrovascular disease in elderly and young healthy subjects[J].临床药理,1997,28(3):693-702.
8Mizuno A,Umemura K,Nakashima M.Inhibitory effect MCI-186,a free radical scavenger,on cerebral ischemia following rat middle cerebral artery occlusion[J].Gen Pharmacol,1998,30(4)∶575-578.
9Kawai H,Nakai H,Misao S,et al.Effects of a novel free radical scavenger,MCI-186,on ischemic brain damage in the rat distal middle cerebral artery occlusion model[J].J Pharmacol Exp Ther,1997,281(2)∶921-927.
6Tanaka M.Pharmacological and clinical profil of the free radical scvenger edarvone as neurotective agent[J].Nippon Yakurigaku Zasshi,2002,119:301.
7Edarvone Acute Infraction Study Group.Effect of a novel free radical scvenger,edarvone (MCI-186) on acute brain infarction.Randomized,placebo-controlled,double-blind study at multicenters[J].Cerebrovasc Dis,2003,15:222.
